
Suresh Agarwal
Surgery Residency · Duke University Hospital
Credentials: · · · · ·
History
2024–Present
- 2000–2001
Research
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Blood · 2017 · 428 citations
Emergency general surgery: definition and estimated burden of disease
The journal of trauma and acute care surgery · 2013 · 304 citations
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
The Lancet Oncology · 2017 · 284 citations

60 papers · 9 as a fellow

17 papers

14 papers

12 papers · 11 as a resident

12 papers

11 papers

11 papers · 2 as a fellow
- MC
11 papers
Grants
- 2025–2030
National Heart, Lung, and Blood Institute · R01
PI · $1.3M · Duke University
Clinical trials
- 2013–2014
Acute Lung Injury Ventilator Evaluation (ALIVE)
Principal investigator · Terminated
University of Wisconsin, Madison



